B6-Niacinamide
90/100
This product looks safe
- Contains proprietary blend — exact ingredient amounts not disclosed
- 67% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed
Label Data
1 Tablet(s)
Serving Size
90
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Supplement Facts — Evidence Check
10 mg
(63% DV)
✅ Within RDA (0.7× RDA of 14 mg)
📚 193 studies (Tier A: 5, B: 63)
50 mg
(2941% DV)
📊 38.5× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
Proprietary Blend
250 mg
Other Ingredients
Pyridoxine Hydrochloride
Honey
Niacinamide
Calcium Stearate
Arabic Gum
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Suggested use: One tablet per day, or as directed.
⚠️ Warnings & Precautions
Caution: This product is processed in a facility that manufactures other products containing soy, milk, egg, wheat, peanut, tree nuts, fish, and shellfish.
🧪 Formulation Notes
Gluten free
Additional Information
Whole food supplements since 1929
Product Details
UPC / SKU
8 12122 01017 7
DSLD Entry Date
2021-11-19
Product Type
Other Combinations
Form
Tablet or Pill
Brand
SP Standard Process
DSLD ID
256280
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100